File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/1756-185X.12313
- Scopus: eid_2-s2.0-84893089050
- PMID: 24472259
- WOS: WOS:000330315200001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Treat to target for rheumatoid arthritis in 2014 – time tested triple therapy or logical biologics?
Title | Treat to target for rheumatoid arthritis in 2014 – time tested triple therapy or logical biologics? |
---|---|
Authors | |
Issue Date | 2014 |
Publisher | Wiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwell-synergy.com/loi/ijrd |
Citation | International Journal of Rheumatic Diseases , 2014, v. 17 n. 1, p. 1-3 How to Cite? |
Description | Open Access Journal |
Persistent Identifier | http://hdl.handle.net/10722/203067 |
ISSN | 2023 Impact Factor: 2.4 2023 SCImago Journal Rankings: 0.653 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mok, TMY | - |
dc.contributor.author | Danda, D | - |
dc.date.accessioned | 2014-09-19T11:29:25Z | - |
dc.date.available | 2014-09-19T11:29:25Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | International Journal of Rheumatic Diseases , 2014, v. 17 n. 1, p. 1-3 | - |
dc.identifier.issn | 1756-1841 | - |
dc.identifier.uri | http://hdl.handle.net/10722/203067 | - |
dc.description | Open Access Journal | - |
dc.language | eng | - |
dc.publisher | Wiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwell-synergy.com/loi/ijrd | - |
dc.relation.ispartof | International Journal of Rheumatic Diseases | - |
dc.rights | Preprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article]. Authors are not required to remove preprints posted prior to acceptance of the submitted version. Postprint This is the accepted version of the following article: [full citation], which has been published in final form at [Link to final article]. | - |
dc.subject.mesh | Antirheumatic Agents - therapeutic use | - |
dc.subject.mesh | Arthritis, Rheumatoid - diagnosis - drug therapy - immunology | - |
dc.subject.mesh | Biological Products - therapeutic use | - |
dc.subject.mesh | Tumor Necrosis Factor-alpha - antagonists and inhibitors | - |
dc.title | Treat to target for rheumatoid arthritis in 2014 – time tested triple therapy or logical biologics? | - |
dc.type | Article | - |
dc.identifier.email | Mok, TMY: temy@hkucc.hku.hk | - |
dc.identifier.authority | Mok, TMY=rp00490 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1111/1756-185X.12313 | - |
dc.identifier.pmid | 24472259 | - |
dc.identifier.scopus | eid_2-s2.0-84893089050 | - |
dc.identifier.hkuros | 235685 | - |
dc.identifier.volume | 17 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 1 | - |
dc.identifier.epage | 3 | - |
dc.identifier.isi | WOS:000330315200001 | - |
dc.publisher.place | Australia | - |
dc.identifier.issnl | 1756-1841 | - |